Cash, cash equivalents, short- and long-term investments, and interest receivable were $439.0 million as of December 31, 2025. Cullinan expects its cash resources to provide runway into 2029 under its current operating plan.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CGEM:
- CGEM Upcoming Earnings Report: What to Expect?
- TheStreet Pro Analysts Say, “It’s a Stock Picker’s Market – Here Are 4 to Consider”
- Cullinan Therapeutics initiated with a Buy at Citi
- Cullinan Oncology: Undervalued Autoimmune Pipeline With 2026 CLN-978 Catalysts and Additional Oncology Upside Supporting Buy Rating
- TheStreet Pro Analysts Say, “Big Tech Names are Anything But Cheap – Buy These 2 Stocks Instead”